Nagaileben Co., Ltd.
Nagaileben Co., Ltd. (7447.T) Financial Performance & Income Statement Overview
Review Nagaileben Co., Ltd. (7447.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Nagaileben Co., Ltd. (7447.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Nagaileben Co., Ltd. 7447.T financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $4.63B | $3.21B | $3.77B | $5.25B |
| Cost of Revenue | $2.79B | $1.93B | $2.20B | $2.98B |
| Gross Profit | $1.84B | $1.28B | $1.56B | $2.27B |
| Gross Profit Ratio | $0.40 | $0.40 | $0.42 | $0.43 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $43.00M |
| SG&A Expenses | $919.85M | $698.00M | $438.00M | $702.97M |
| Operating Expenses | $919.85M | $699.00M | $693.00M | $745.97M |
| Total Costs & Expenses | $3.71B | $2.63B | $2.89B | $3.73B |
| Interest Income | $6.61M | $0.00 | $6.32M | $2.14M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $66.80M | $66.50M | $209.38M | $67.23M |
| EBITDA | $1.008B | $646.50M | $1.08B | $1.52B |
| EBITDA Ratio | $0.22 | $0.20 | $0.29 | $0.29 |
| Operating Income | $919.84M | $579.00M | $872.70M | $1.52B |
| Operating Income Ratio | $0.20 | $0.18 | $0.23 | $0.29 |
| Other Income/Expenses (Net) | $21.43M | $22.00M | $19.15M | $19.22M |
| Income Before Tax | $941.27M | $601.00M | $891.85M | $1.54B |
| Income Before Tax Ratio | $0.20 | $0.19 | $0.24 | $0.29 |
| Income Tax Expense | $292.42M | $188.00M | $265.37M | $476.14M |
| Net Income | $648.85M | $413.00M | $626.49M | $1.07B |
| Net Income Ratio | $0.14 | $0.13 | $0.17 | $0.20 |
| EPS | $20.82 | $13.16 | $19.83 | $33.56 |
| Diluted EPS | $20.82 | $13.16 | $19.83 | $33.56 |
| Weighted Avg Shares Outstanding | $31.16M | $31.38M | $31.59M | $31.78M |
| Weighted Avg Shares Outstanding (Diluted) | $31.16M | $31.38M | $31.59M | $31.78M |
Over the last four quarters, Nagaileben Co., Ltd. achieved steady financial progress, growing revenue from $5.25B in Q3 2024 to $4.63B in Q2 2025. Gross profit stayed firm with margins at 40% in Q2 2025 versus 43% in Q3 2024. Operating income totaled $919.84M in Q2 2025, maintaining a 20% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.008B. Net income rose to $648.85M, with EPS at $20.82. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan